{"id":"https://openalex.org/W3177711368","doi":"https://doi.org/10.1002/cncr.33689","title":"Outcomes of TP53\u2010mutant acute myeloid leukemia with decitabine and venetoclax","display_name":"Outcomes of TP53\u2010mutant acute myeloid leukemia with decitabine and venetoclax","publication_year":2021,"publication_date":"2021-07-13","ids":{"openalex":"https://openalex.org/W3177711368","doi":"https://doi.org/10.1002/cncr.33689","mag":"3177711368","pmid":"https://pubmed.ncbi.nlm.nih.gov/34255353","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10462434"},"language":"en","primary_location":{"id":"doi:10.1002/cncr.33689","doi":"https://doi.org/10.1002/cncr.33689","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cncr.33689","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10462434/pdf/nihms-1917432.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086011253","display_name":"Kunhwa Kim","orcid":"https://orcid.org/0000-0002-9709-6824","observed_orcids":["https://orcid.org/0000-0002-9709-6824"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kunhwa Kim","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":"https://orcid.org/0000-0002-9709-6824","affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075581944","display_name":"Abhishek Maiti","orcid":"https://orcid.org/0000-0001-9043-538X","observed_orcids":["https://orcid.org/0000-0001-9043-538X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abhishek Maiti","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056317446","display_name":"Sanam Loghavi","orcid":"https://orcid.org/0000-0001-8980-3202","observed_orcids":["https://orcid.org/0000-0001-8980-3202"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanam Loghavi","raw_affiliation_strings":["Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013304167","display_name":"Rasoul Pourebrahim","orcid":"https://orcid.org/0000-0003-1175-2032","observed_orcids":["https://orcid.org/0000-0003-1175-2032"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rasoul Pourebrahim","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020340537","display_name":"Tapan Mahendra Kadia","orcid":"https://orcid.org/0000-0002-9892-9832","observed_orcids":["https://orcid.org/0000-0002-9892-9832"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tapan M. Kadia","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":"https://orcid.org/0000-0002-9892-9832","affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050975340","display_name":"Caitlin R. Rausch","orcid":"https://orcid.org/0000-0002-4166-5717","observed_orcids":["https://orcid.org/0000-0002-4166-5717"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caitlin R. Rausch","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":"https://orcid.org/0000-0002-4166-5717","affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003535995","display_name":"Ken Furudate","orcid":"https://orcid.org/0000-0003-1272-5490","observed_orcids":["https://orcid.org/0000-0003-1272-5490"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I146516829","display_name":"Hirosaki University","ror":"https://ror.org/02syg0q74","country_code":"JP","type":"education","lineage":["https://openalex.org/I146516829"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Ken Furudate","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","Department of Oral and Maxillofacial Surgery, Hirosaki University Graduate School of Medicine, Aomori, Japan"],"raw_orcid":"https://orcid.org/0000-0003-1272-5490","affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Oral and Maxillofacial Surgery, Hirosaki University Graduate School of Medicine, Aomori, Japan","institution_ids":["https://openalex.org/I146516829"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035605515","display_name":"Naval Guastad Daver","orcid":"https://orcid.org/0000-0001-7103-373X","observed_orcids":["https://orcid.org/0000-0001-7103-373X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naval G. Daver","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":"https://orcid.org/0000-0001-7103-373X","affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070065917","display_name":"Yesid Alvarado","orcid":"https://orcid.org/0000-0002-1652-7937","observed_orcids":["https://orcid.org/0000-0002-1652-7937"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yesid Alvarado","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009316700","display_name":"Maro N. Ohanian","orcid":"https://orcid.org/0000-0002-1689-4470","observed_orcids":["https://orcid.org/0000-0002-1689-4470"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maro Ohanian","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029750735","display_name":"Koji Sasaki","orcid":"https://orcid.org/0000-0002-9140-0610","observed_orcids":["https://orcid.org/0000-0002-9140-0610"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Koji Sasaki","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":"https://orcid.org/0000-0002-9140-0610","affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091492845","display_name":"Nicholas James Short","orcid":"https://orcid.org/0000-0002-2983-2738","observed_orcids":["https://orcid.org/0000-0002-2983-2738"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas J. Short","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":"https://orcid.org/0000-0002-2983-2738","affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051949215","display_name":"Koichi Takahashi","orcid":"https://orcid.org/0000-0002-8027-9659","observed_orcids":["https://orcid.org/0000-0002-8027-9659"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Koichi Takahashi","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050041791","display_name":"Musa E. Yilmaz","orcid":"https://orcid.org/0000-0002-4498-4895","observed_orcids":["https://orcid.org/0000-0002-4498-4895","https://orcid.org/0000-0001-9557-678X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Musa Yilmaz","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055404021","display_name":"Guilin Tang","orcid":"https://orcid.org/0000-0002-9482-4806","observed_orcids":["https://orcid.org/0000-0002-9482-4806"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guilin Tang","raw_affiliation_strings":["Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000750846","display_name":"Farhad Ravandi","orcid":"https://orcid.org/0000-0002-7621-377X","observed_orcids":["https://orcid.org/0000-0002-7621-377X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Farhad Ravandi","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop M. Kantarjian","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":"https://orcid.org/0000-0002-1908-3307","affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010786159","display_name":"Courtney Denton Dinardo","orcid":"https://orcid.org/0000-0001-9003-0390","observed_orcids":["https://orcid.org/0000-0001-9003-0390"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtney D. DiNardo","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":"https://orcid.org/0000-0001-9003-0390","affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022647201","display_name":"Marina Y Konopleva","orcid":"https://orcid.org/0000-0002-9347-2212","observed_orcids":["https://orcid.org/0000-0002-9347-2212"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marina Y. Konopleva","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5022647201"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":17.81,"has_fulltext":true,"cited_by_count":172,"citation_normalized_percentile":{"value":0.99568853,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"127","issue":"20","first_page":"3772","last_page":"3781"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9539999961853027},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":1.0},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":0.9419999718666077},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":1.0},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.824999988079071},{"id":"https://openalex.org/keywords/venetoclax-resistance","display_name":"venetoclax resistance","score":0.9070000052452087},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6499999761581421},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.7739999890327454},{"id":"https://openalex.org/keywords/secondary-acute-myeloid-leukemia","display_name":"secondary acute myeloid leukemia","score":0.6320000290870667},{"id":"https://openalex.org/keywords/complex-karyotype","display_name":"complex karyotype","score":0.9599999785423279},{"id":"https://openalex.org/keywords/variant-allele-frequency","display_name":"variant allele frequency","score":0.8109999895095825},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.5090000033378601},{"id":"https://openalex.org/keywords/induction-therapy","display_name":"induction therapy","score":0.45399999618530273},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9481329917907715},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.9461972713470459},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8772684335708618},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6450954675674438},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6355887651443481},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.5779060125350952},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.5637614727020264},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.5428183078765869},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.47089439630508423},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4495936930179596},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4390050172805786},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4336240291595459},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40688154101371765},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.12148869037628174},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.10871002078056335},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07474040985107422},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077209","descriptor_name":"Decitabine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/cncr.33689","doi":"https://doi.org/10.1002/cncr.33689","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cncr.33689","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:34255353","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34255353","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10462434","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10462434","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10462434/pdf/nihms-1917432.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:10462434","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10462434","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10462434/pdf/nihms-1917432.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1380303112","display_name":"Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen","funder_award_id":"R01CA235622","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1468253849","display_name":null,"funder_award_id":"(CA016672)","funder_id":"https://openalex.org/F4320332521","funder_display_name":"University of Texas MD Anderson Cancer Center"},{"id":"https://openalex.org/G4545600481","display_name":"Targeting mitochondrial complex I in acute lymphoblastic leukemia","funder_award_id":"R01CA231364","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000878657","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308982","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320309165","display_name":"FibroGen","ror":"https://ror.org/03sxe1905"},{"id":"https://openalex.org/F4320312286","display_name":"Ablynx","ror":"https://ror.org/05s030550"},{"id":"https://openalex.org/F4320312570","display_name":"Jazz Pharmaceuticals","ror":"https://ror.org/055mhsv54"},{"id":"https://openalex.org/F4320314605","display_name":"Astex Pharmaceuticals","ror":"https://ror.org/05fx1fs38"},{"id":"https://openalex.org/F4320316491","display_name":"MEI Pharma","ror":"https://ror.org/02bgfrc80"},{"id":"https://openalex.org/F4320316629","display_name":"Agios Pharmaceuticals","ror":"https://ror.org/002x06r10"},{"id":"https://openalex.org/F4320316872","display_name":"Adaptive Biotechnologies","ror":"https://ror.org/01gbt6a54"},{"id":"https://openalex.org/F4320317987","display_name":"Syndax Pharmaceuticals","ror":"https://ror.org/02w9kv048"},{"id":"https://openalex.org/F4320319264","display_name":"MacroGenics","ror":"https://ror.org/01hcd4187"},{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320327847","display_name":"SymBio Pharmaceuticals Limited","ror":"https://ror.org/02g42wq61"},{"id":"https://openalex.org/F4320328070","display_name":"Sun Pharma","ror":"https://ror.org/04vnqkx80"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332521","display_name":"University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3177711368.pdf","grobid_xml":"https://content.openalex.org/works/W3177711368.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1968846332","https://openalex.org/W2058794589","https://openalex.org/W2081391009","https://openalex.org/W2129769331","https://openalex.org/W2159792943","https://openalex.org/W2419140434","https://openalex.org/W2499799649","https://openalex.org/W2549790759","https://openalex.org/W2559537906","https://openalex.org/W2618059744","https://openalex.org/W2760499085","https://openalex.org/W2773114573","https://openalex.org/W2783500974","https://openalex.org/W2790450422","https://openalex.org/W2905325447","https://openalex.org/W2940002383","https://openalex.org/W2942538710","https://openalex.org/W2944248311","https://openalex.org/W2969217862","https://openalex.org/W2982797651","https://openalex.org/W2999354194","https://openalex.org/W3000515035","https://openalex.org/W3046671820","https://openalex.org/W3048827006","https://openalex.org/W3083003645","https://openalex.org/W3095208864","https://openalex.org/W3101740872","https://openalex.org/W3191995160","https://openalex.org/W4233833032","https://openalex.org/W7225803152"],"related_works":["https://openalex.org/W3097401397","https://openalex.org/W4417009377","https://openalex.org/W3175636756","https://openalex.org/W4379281983","https://openalex.org/W4310127741","https://openalex.org/W2961722038","https://openalex.org/W4286297013","https://openalex.org/W4417015779","https://openalex.org/W7162676528","https://openalex.org/W4410809614"],"abstract_inverted_index":{"Background":[0],"TP53":[1,147,163,193,240],"mutation":[2,174],"(TP53mut)":[3],"confers":[4,30],"an":[5,196],"adverse":[6],"prognosis":[7],"in":[8,95,181,282],"acute":[9],"myeloid":[10],"leukemia":[11],"(AML).":[12],"Venetoclax":[13],"with":[14,41,47,59,102,136,188,195,211,236,280,284,292,298,308],"hypomethylating":[15],"agents":[16],"is":[17],"a":[18,48,161,207,224],"current":[19],"standard":[20],"for":[21,67,75,80],"older":[22],"patients;":[23],"however,":[24],"recent":[25],"reports":[26],"suggest":[27],"that":[28],"TP53mut":[29,42,92,143,185,237,285,299],"resistance":[31],"to":[32,72,110,289],"venetoclax.":[33],"The":[34,85,145],"authors":[35],"investigated":[36],"the":[37],"outcomes":[38],"of":[39,104,200,216,227],"patients":[40,118,157,182,283],"AML":[43,62,135,186,286,300],"who":[44,183,190],"were":[45,107,178,287],"treated":[46],"10\u2010day":[49,293],"decitabine":[50,64,79,294],"and":[51,139,170,175,223,260,305],"venetoclax":[52,86],"(DEC10\u2010VEN)":[53],"(ClinicalTrials.gov":[54],"identifier":[55],"NCT03404193).":[56],"Methods":[57],"Patients":[58,235,297],"newly":[60],"diagnosed":[61],"received":[63],"20":[65],"mg/m2":[66],"10":[68],"days":[69,82],"every":[70],"4":[71],"6":[73],"weeks":[74],"induction,":[76],"followed":[77],"by":[78],"5":[81],"after":[83],"response.":[84],"dose":[87],"was":[88,93,151],"400":[89],"mg":[90],"daily.":[91],"identified":[94],"bone":[96],"marrow":[97],"samples":[98],"using":[99],"next\u2010generation":[100],"sequencing,":[101],"sensitivity":[103],"5%.":[105],"Outcomes":[106,177,279],"analyzed":[108],"according":[109],"European":[111],"LeukemiaNet":[112],"2017":[113],"guidelines.":[114],"Results":[115],"Among":[116],"118":[117],"(median":[119],"age,":[120],"72":[121],"years;":[122],"age":[123],"range,":[124,154],"49\u201089":[125],"years),":[126],"63":[127],"(53%)":[128],"had":[129,134,142,159,167,173,184,191,241],"secondary":[130],"AML,":[131,194],"39":[132],"(33%)":[133],"complex":[137],"karyotype,":[138],"35":[140],"(30%)":[141],"AML.":[144],"median":[146],"variant":[148],"allele":[149],"frequency":[150],"32%":[152],"(interquartile":[153],"16%\u201065%),":[155],"8":[156],"(23%)":[158],"only":[160],"single":[162],"mutation,":[164],"15":[165],"(43%)":[166],"multiple":[168],"mutations,":[169],"12":[171],"(34%)":[172],"deletion.":[176],"significantly":[179],"worse":[180],"compared":[187],"those":[189],"wild\u2010type":[192,239],"overall":[197,243],"response":[198,210,303],"rate":[199,215],"66%":[201],"vs":[202,218,229],"89%":[203],"(P":[204,220,231],"=":[205,221],".002),":[206],"complete":[208],"response/complete":[209],"incomplete":[212],"hematologic":[213],"recovery":[214],"57%":[217],"77%":[219],".029),":[222],"60\u2010day":[225],"mortality":[226],"26%":[228],"4%":[230],"<":[232,258,276],".001),":[233],"respectively.":[234,278],"versus":[238,247,266],"shorter":[242,261,306],"survival":[244,263,307],"at":[245,264],"5.2":[246],"19.4":[248],"months,":[249],"respectively":[250],"(hazard":[251,269],"ratio,":[252,270],"4.67;":[253],"95%":[254,272],"CI,":[255,273],"2.44\u20108.93;":[256],"P":[257,275],".0001),":[259,277],"relapse\u2010free":[262],"3.4":[265],"18.9":[267],"months":[268],"4.80;":[271],"1.97\u201011.69;":[274],"DEC10\u2010VEN":[281],"comparable":[288],"historical":[290],"results":[291],"alone.":[295],"Conclusions":[296],"have":[301],"lower":[302],"rates":[304],"DEC10\u2010VEN.":[309]},"counts_by_year":[{"year":2026,"cited_by_count":34},{"year":2025,"cited_by_count":27},{"year":2024,"cited_by_count":26},{"year":2023,"cited_by_count":46},{"year":2022,"cited_by_count":31},{"year":2021,"cited_by_count":8}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2021-07-19T00:00:00"}